Endocrinology
Trilostane for Dogs With Hyperadrenocorticism
The primary goals of trilostane therapy are resolving clinical signs of hyperadrenocorticism and avoiding oversuppression of the adrenal axis.
Menu
DVM, MS, DACVIM
Dr. Archer is associate professor and service chief in the Department of Clinical Sciences at Mississippi State University College of Veterinary Medicine, where he received his DVM degree and completed an internship and residency. His research focuses on hematology and immune-mediated disorders, especially use of immunosuppressive therapy.
The primary goals of trilostane therapy are resolving clinical signs of hyperadrenocorticism and avoiding oversuppression of the adrenal axis.
Stay current with the latest techniques and information – sign up below to start your FREE Today’s Veterinary Practice subscription today.
Start My SubscriptionTo provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.